Published in Cell · View the paper (DOI)
A NIH-funded team developed a method to evaluate how mutations in the SARS-CoV-2 N protein affect recognition by antibodies used in rapid antigen tests. The study found that none of the major past and present variants of concern contain N protein mutations affecting diagnostic antibody performance.
Coverage from 2 institutions